The complex interplay between aging and cancer presents a rich field for investigation. "Aging and Oncology: Molecular Insights and Therapeutic Advances" explores the complex interplay between aging and cancer, highlighting innovative treatment approaches and drug resistance associated with aging, alongside tailored therapeutic strategies for elderly cancer patients in clinical contexts. Understanding the molecular network of aging that contributes to cancer progression, novel drug development and treatment resistance is crucial for controlling cancer. Furthermore, this Research Topic underscores the necessity of clinical trials incorporating elderly patients to investigate personalized treatment strategies for the aging population. Addressing these challenges head-on can lead to more effective, safer, and personalized cancer care strategies for cancer patients, ultimately improving their quality of life and treatment success.
In this Research Topic, we aimed to comprehensively dissect the molecular mechanisms through which aging influences the initiation and progression of tumors. Furthermore, we endeavored to advance the development of cancer treatments that target aging mechanisms and overcome aging-related drug resistance, alongside crafting personalized treatment plans for elderly cancer patients in clinical practice.
We invite submissions of original research articles, comprehensive reviews, meta-analyses, and perspective pieces that contribute to advancing our understanding of aging and oncology. Furthermore, innovative methodologies and experimental approaches aimed at unraveling the complexities of these phenomena are highly encouraged.
This Research Topic will explore various aspects related to aging and oncology. Subtopics may include but are not limited to:
• Molecular mechanisms of aging in tumor development;
• Development of novel drugs targeting the mechanisms by which aging influences tumor genesis and progression;
• The mechanism behind aging-related drug resistance in cancer;
• Exploration of personalized treatment plans for aging cancer patients.
Please NOTE: Manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases that are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of the scope of this section and will not be accepted as part of this Research Topic.
Keywords:
aging, cancer, drug resistance, progression
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
The complex interplay between aging and cancer presents a rich field for investigation. "Aging and Oncology: Molecular Insights and Therapeutic Advances" explores the complex interplay between aging and cancer, highlighting innovative treatment approaches and drug resistance associated with aging, alongside tailored therapeutic strategies for elderly cancer patients in clinical contexts. Understanding the molecular network of aging that contributes to cancer progression, novel drug development and treatment resistance is crucial for controlling cancer. Furthermore, this Research Topic underscores the necessity of clinical trials incorporating elderly patients to investigate personalized treatment strategies for the aging population. Addressing these challenges head-on can lead to more effective, safer, and personalized cancer care strategies for cancer patients, ultimately improving their quality of life and treatment success.
In this Research Topic, we aimed to comprehensively dissect the molecular mechanisms through which aging influences the initiation and progression of tumors. Furthermore, we endeavored to advance the development of cancer treatments that target aging mechanisms and overcome aging-related drug resistance, alongside crafting personalized treatment plans for elderly cancer patients in clinical practice.
We invite submissions of original research articles, comprehensive reviews, meta-analyses, and perspective pieces that contribute to advancing our understanding of aging and oncology. Furthermore, innovative methodologies and experimental approaches aimed at unraveling the complexities of these phenomena are highly encouraged.
This Research Topic will explore various aspects related to aging and oncology. Subtopics may include but are not limited to:
• Molecular mechanisms of aging in tumor development;
• Development of novel drugs targeting the mechanisms by which aging influences tumor genesis and progression;
• The mechanism behind aging-related drug resistance in cancer;
• Exploration of personalized treatment plans for aging cancer patients.
Please NOTE: Manuscripts consisting solely of bioinformatics or computational analysis of public genomic or transcriptomic databases that are not accompanied by validation (independent cohort or biological validation in vitro or in vivo) are out of the scope of this section and will not be accepted as part of this Research Topic.
Keywords:
aging, cancer, drug resistance, progression
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.